web analytics
23.8 C
Munich
Saturday, July 2, 2022

The Latest on Bravatek Solutions Inc (OTCMKTS:BVTK)

Bravatek Solutions Inc (OTCMKTS:BVTK) was up on Friday while the rest of the markets suffered big losses concluding the worse week since 2008. BVTK on Friday turned out to be one of the few winners.

BVTK was up after the Company announced it has received a detailed report from its partner, Zoono, that the third party, independent laboratory tests undertaken against COVID-19 showed that Zoono’s Z-71 Microbe Shield (the same Zoono technology used in Zoono hand sanitizer) is > 99.99% effective against COVOID-19. The product sanitizes and kills the virus.

Bravatek Solutions Inc (OTCMKTS:BVTK) bills itself as a high technology security solutions portfolio provider that assists corporate entities, governments and individuals protect their organizations against both physical and cyber-attacks through its offering of the most technically advanced, cost-effective and reliable software, tools and systems.

Microcapdaily has reported on BVTK many times in the past, on January 4, 2016 we reported: “BVTK” is making an explosive move up on accelerating volume after the Company announced an LOI with construction company YKTG, LLC, for a $10-million plus decommissioning project with a major cell phone carrier. BVTK is the new ticker symbol for ECRY. The symbol change comes after a 10 for 1 reverse split affected on December 4.

To find out the real inside scoop on BVTK Subscribe below Right Now

BVTK

Earlier this year BVTK reported it entered into a Strategic Alliance Agreement with Z Systems, with headquarters in northern New Jersey.  The agreement was entered into following BVTK’s agreement with ZoonoUSA, a manufacturer and supplier of advanced technology products that offer germ protection, long after the product is applied, by creating a protective shield on the surface it is applied to. This shield lasts about 30 days on surfaces and 24 hours on skin, when natural exfoliation occurs.

On February 28 BVTK announced it has received a detailed report from its partner, Zoono, that the third party, independent laboratory tests undertaken against COVID-19 showed that Zoono’s Z-71 Microbe Shield (the same Zoono technology used in Zoono hand sanitizer) is > 99.99% effective against COVOID-19. The product sanitizes and kills the virus. COVID-19 has become a global concern, as it has been shown to survive on surfaces for up to nine days. Zoono products have been successfully tested against a variety of pathogens for up to 30 days on surfaces and 24 hours on hands.

Bravatek says it is spearheading the team and will begin immediately providing samples, as well as rigorous test and evaluation results to both military and government agencies for review, as already discussed in meetings with US government officials. While Zoono formulations have been previously tested against bovine coronavirus (the nominated surrogate for MERS), this latest strain required new testing. To that end, two separate tests were completed to EN Standard 14476:2013+A2:2019. The first was against Vaccinia; sometimes referred to as the “mother ship” of double enveloped viruses (that are particularly hard to inactivate), with the subsequent test against the nominated (and globally accepted) surrogate for COVID-19, feline coronavirus.

We have a Monster Pick Coming. Subscribe Right Now!

Currently on the move BVTK it at least getting their filings out on time posting a 10Q on November 15, 2019; the Company has no cash and $8.8 million in current liabilities which can cause serious dilution. Revenues were $112k for the 3 months ended September 30, 2019. Current shareholders are excited if not a bit wary.  We will be updating on BVTK when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with BVTK.

WAIT! Do You Want Stocks That Could Go Up 348% In Days Delivered To Your Inbox For FREE?

Disclosure: we hold no position in BVTK either long or short and we have not been compensated for this article.

Ali Raza
A journalist, with experience in web journalism and marketing. Ali holds a master degree in finance and enjoys writing about cryptocurrencies and fintech. Ali’s work has been published on a number of cryptocurrency publications.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.